Page 52 - GPD-3-1
P. 52

Gene & Protein in Disease                                              Prognostic potential of LMNB2 in LPS




             A                                    B                           C


















             D
                                         E
                                                                              F
















            Figure 3. Expression features and ROC curves of LMNB2 in different subtypes of LPS. (A) Differences in LMNB2 expression levels between normal and
            tumor tissues. (B and C) The level of LMNB2 expression varies in patients with different subtypes. (D and E) ROC curves of the expression of LMNB2 in
            normal and LPS tissues. (F) LMNB2 expression discrimination between DDLPS and WDLPS.
            Abbreviations: DDLPS: Dedifferentiated liposarcoma; LPS: Liposarcoma; ROC: Receiver operating characteristic; WDLPS: Well-differentiated liposarcoma.

            3.3. Significant correlation between LMNB2           To determine whether the expression of LMNB2 could
            expression and poor prognosis in LPS patients      serve as an independent risk factor for LPS prognosis, both
            The prognostic value of LMNB2 was further determined by   univariate and multivariate analyses were conducted. The
            mapping Kaplan–Meier curves for overall survival (OS) and   univariate analysis  revealed that  LMNB2 expression  and
            distant relapse-free survival (DRFS) in LPS patients. In patients   therapy  outcome  (progressive  disease)  were  significantly
            with DDLPS, the high expression of LMNB2 predicted poor OS   associated with a higher prognostic risk (Table  1).
            (P = 0.0091) (Figure 4A) and DRFS (P = 0.0198) (Figure 4B).   Subsequent multivariate analysis further revealed that
            In addition, patients with higher LMNB2 expression exhibited   LMNB2 expression or therapy outcome (progressive
            significantly shorter DRFS time than those with lower LMNB2   disease) could be considered independent prognostic risk
            expression across all subtypes (P  = 0.0003) (Figure  4C),   factors for LPS (Table 1).
            consistent with the correlation observed between the two
            survival curves of DDLPS (OS and DRFS).            3.4. Construction of gene-gene and PPI network of
                                                               LMNB2
              Moreover, we also plotted Kaplan–Meier curves for
            patients with different clinicopathological characteristics,   A gene-gene interaction network of  LMNB2 was
            including age ≥60 (P = 0.0058) (Figure 4D), male gender   constructed, and its function was analyzed using the
            (P  = 0.0028) (Figure  4E), and absence of new tumor   GeneMANIA database (Figure  5A). At the mRNA
            events after initial treatment (P = 0.0381) (Figure 4F). The   level, the  LMNB2 gene is surrounded  by 20  nodes that
            survival time significantly differed between the high and   represent the top 20 genes associated with  LMNB2 in
            low LMNB2 expression groups across these pathological   terms of physical interactions, coexpression, predictions,
            characteristics.                                   co-localization, and genetic interactions (Figure 5A). The


            Volume 3 Issue 1 (2024)                         6                        https://doi.org/10.36922/gpd.2607
   47   48   49   50   51   52   53   54   55   56   57